AmilcarLuisMoralesMD
Gastroenterology • Fort Worth, TXHepatology & Liver Transplantation
Texas Digestive Disease Consultants, Fort Worth, Tx
Dr. Morales is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6317 Harris Pkwy
ste 300
Fort Worth, TX 76132Phone+1 817-361-6900
Summary
- Dr. Amilcar Morales is a gastroenterologist in Fort Worth TX and is affiliated with Texas Digestive Disease Consultants. He received his medical degree from University of Puerto Rico School of Medicine and has been in practice 7 years. He also speaks multiple languages, including Spanish. He specializes in hepatology & liver transplantation.
Education & Training
MedStar Health/Georgetown University HospitalPost-Doctoral Fellowship, Transplant Hepatology, 2015 - 2016
National Capital ConsortiumFellowship, Gastroenterology, 2013 - 2016
San Antonio Uniformed Services Health Education ConsortiumResidency, Internal Medicine, 2010 - 2013
University of Puerto Rico School of MedicineClass of 2010
Certifications & Licensure
TX State Medical License 2020 - 2026
VA State Medical License 2012 - 2026
DC State Medical License 2014 - 2016- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
- American Board of Internal Medicine Transplant Hepatology
Publications & Presentations
PubMed
- 88 citationsRole of Cholesterol-Associated Steatohepatitis in the Development of NASH.Christian L. Horn, Amilcar Morales, Christopher E. Savard, Geoffrey C. Farrell, George N. Ioannou
Hepatology Communications. 2021-08-24 - 38 citationsHepatitis C eradication with sofosbuvir leads to significant metabolic changes.Amilcar Morales, Zachary Junga, Manish B Singla, Maria Sjogren, Dawn Torres
World Journal of Hepatology. 2016-12-18 - 22 citationsLedipasvir/sofosbuvir is effective and well tolerated in postkidney transplant patients with chronic hepatitis C virus.Amilcar Morales, Luz Liriano-Ward, Amber Tierney, Michelle Lee Sang, Alexander Lalos
Clinical Transplantation. 2017-05-01
Professional Memberships
- Associate
- Member
- Member
Other Languages
- Spanish
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
